Gene therapy for Crigler Najjar syndrome: results of the dose finding part of the CareCN, phase 1-2 clinical trial. - D'Antiga, L.; Beuers, U.; Brunetti-Pierri, N.; Baumann, U.; Di Giorgio, A.; Aronson, S.; Hubert, A.; Romano, R.; Junge, N.; Bosma, P.; Bortolussi, G.; Muro, A. F.; et al. (Journal of pediatric gastroenterology and nutrition, 2022)